Scotland offers comprehensive services to biopharmaceutical collaborators around the world. Global biopharmaceutical firms have the capital and resources to go anywhere in the world in their search for top talent, innovative product research, cost-efficient investment opportunities, and the right support and services for product development and production. With one of the largest and most dynamic life science sectors in the UK and the wider EU,...
Vascutek and Bolton Medical, subsidiaries of Terumo Corporation of Japan, have combined into Terumo Aortic. Combining the aortic companies into a single business, Terumo looks to grow its presence in the global aortic and vascular implants market. The new company brings together two leaders in the aortic implant market. The new identity underlines Terumo’s global growth ambitions, further to a previous US$43 million factory investment. Known as...
RoslinCT, a UK-based cell and gene therapy contract manufacturing organisation, is delighted to be part of the Northern Alliance Advanced Therapies Treatment Centre (NAATTC) consortium. As an industry partner within the consortium, RoslinCT will provide advice on the development, manufacture and clinical supply of cell, gene and tissue engineered therapies. Unlike most conventional medicinal products, advanced therapies offer the potential to cure many degenerative diseases...
Transfusion diagnostics company, Quotient, has official opened its state-of-the-art Allan-Robb Campus within the Scottish Enterprise Biocampus just outside of Edinburgh. Paul Cowan, Founder of Quotient, said, “The inauguration of the Allan-Robb Campus testifies to Quotient’s long-term commitment to the global transfusion diagnostics market, both through the on-going supply of liquid reagents and through its transformational MosaiQ™ transfusion diagnostics system that provides a comprehensive automated testing solution,...
Quotient Limited, a commercial-stage diagnostics company, today announced the appointment of Franz Walt to its board of directors effective February 19, 2018 Mr. Walt joins Quotient’s board of directors with over 29 years of experience in leadership roles at two of the largest, most influential healthcare companies, Siemens Healthineers and Roche, and serves as an expert advisor on the in-vitro diagnostics industry to manufacturing companies and private equity firms....
Tokyo-based Terumo Corporation has today announced an investment of £33 million in one of its subsidiary companies, Vascutek Limited, located near Glasgow. The investment has been approved for the major expansion of Vascutek’s headquarters and manufacturing facility at Inchinnan, Renfrewshire to help drive further growth for the global medical device company. Vascutek produces a wide portfolio of implants with a particular focus on treating patients...
Cobra Biologics and Symbiosis awarded £1.9m ($2.5m USD) Innovate UK Grant Funding from the Health and Life Sciences Programme, will be used to develop world-leading capabilities in drug substance and drug product viral vector production for gene and immunotherapy. Cobra Biologics (Cobra), an international contract development and manufacturing organisation (CDMO) of biologics and pharmaceuticals, and Symbiosis Pharmaceutical Services (Symbiosis), a contract manufacturing organisation (CMO) specialising...
Lonza’s integrated development and manufacturing site for biopharmaceutical liquid-filled hard capsules has new anti-counterfeiting security capabilities in place and is now in full compliance with EU and U.S. regulatory requirements for serialization. With increasing threats to patient safety from counterfeited and diverted pharmaceuticals, new rules for serialization in more than 40 countries are being implemented to secure the world’s pharmaceutical supply chain. To read the full...
CMAC (Continuous Manufacturing and Advanced Crystallisation), a pre-competitive consortium led by the University of Strathclyde to accelerate progress in pharmaceutical manufacturing, announces that Pfizer Inc has joined as a strategic member, alongside GSK, AZ, Novartis, Bayer, Takeda, Lilly and Roche. CMAC is a world-class national centre in advanced pharmaceutical manufacturing, focusing on accelerating the adoption of continuous manufacturing for the production of medicines with a...
Following the Scotsman Life Sciences Conference on 21st November, Life Sciences Scotland have developed a new mini series to address key issues and business concerns raised through discussions at the event. The aim is to sign-post where to find information relevant to the industry. The first mini-series shared through social media began on the 11th December with a focus on Funding & Support available to...